We compared the expression profiles of ascites-derived cells before and after a cycle of mFOLFIRI, comprising fluorouracil (5-FU), leucovorin, and irinotecan, which kill cancer cells via the inhibition of thymidylate synthase and topoisomerase I enzymes. Here, TYMS is linked to cancer.